Piramal Pharma's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the company's site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client needs in drug development and on-patent projects.

As part of the company's sustainability efforts, the Digwal site is equipped with a 'Zero Liquid Discharge' facility to ensure all liquid waste gets adequately treated in-house and recycled back to utilities. The solvent recovery infrastructure has also been upgraded, resulting in increased distillation efficiency and a reduction in solvent consumption. In addition, close monitoring and improved governance have helped in reducing the overall freshwater consumption. PPS is also investigating opportunities to deploy green chemistries for some large volume products.

Based on the company's continued focus on Environmental, Health & Safety (EHS), the site was able to secure Environmental Clearance (EC) for the multi-fold expansion by the concerned authorities, covering the site for the growth envisaged in the next 7-10 years.

In addition to the increased reactor capacity, the Digwal site will benefit from infrastructure upgrades that include a renovated administration block, a new canteen facility, Quality Control lab revamp, and more. The consolidation and creation of a centralized new warehouse for the storage of finished goods that features a warehouse management system (WMS) are currently underway.